Biotricity Price to Sales Ratio 2015-2024 | BTCY
Historical PS ratio values for Biotricity (BTCY) over the last 10 years. The current P/S ratio for Biotricity as of May 06, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Biotricity P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-05-05 | 0.49 | 0.56 | |
| 2024-12-31 | 0.29 | $0.87 | 0.33 |
| 2024-09-30 | 0.24 | $1.06 | 0.22 |
| 2024-06-30 | 0.90 | $1.24 | 0.73 |
| 2024-03-31 | 1.48 | $1.36 | 1.09 |
| 2023-12-31 | 1.15 | $1.32 | 0.87 |
| 2023-09-30 | 2.14 | $1.27 | 1.68 |
| 2023-06-30 | 3.83 | $1.22 | 3.13 |
| 2023-03-31 | 2.79 | $0.92 | 3.05 |
| 2022-12-31 | 2.69 | $0.88 | 3.05 |
| 2022-09-30 | 4.80 | $0.83 | 5.75 |
| 2022-06-30 | 10.62 | $0.81 | 13.09 |
| 2022-03-31 | 13.62 | $1.04 | 13.07 |
| 2021-12-31 | 23.88 | $0.95 | 25.18 |
| 2021-09-30 | 17.64 | $0.87 | 20.18 |
| 2021-06-30 | 18.87 | $0.74 | 25.44 |
| 2021-03-31 | 14.37 | $0.54 | 26.38 |
| 2020-12-31 | 4.43 | $0.42 | 10.66 |
| 2020-09-30 | 6.66 | $0.32 | 20.96 |
| 2020-06-30 | 8.20 | $0.26 | 32.07 |
| 2020-03-31 | 5.84 | $0.24 | 24.61 |
| 2019-12-31 | 3.78 | $0.21 | 18.10 |
| 2019-09-30 | 3.48 | $0.17 | 20.92 |
| 2019-06-30 | 3.96 | $0.12 | 32.02 |
| 2019-03-31 | 5.46 | $0.07 | 76.20 |
| 2018-12-31 | 2.88 | $0.04 | 72.55 |
| 2018-09-30 | 11.46 | $0.02 | 607.00 |
| 2018-06-30 | 18.96 | $0.00 | 0.00 |
| 2018-03-31 | 22.14 | 0 | 0.00 |
| 2017-12-31 | 45.54 | 0 | 0.00 |
| 2017-09-30 | 13.08 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.012B | $0.012B |
| Biotricity Inc. is a medical technology company. It focused on delivering innovative, remote biometric monitoring solutions to the medical and consumer markets, including diagnostic and post-diagnostic solutions for chronic conditions and lifestyle improvement. Biotricity Inc. is based in Toronto, Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.557B | 53.26 |
| Tempus AI (TEM) | United States | $9.312B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $9.304B | 97.39 |
| Inspire Medical Systems (INSP) | United States | $4.724B | 73.15 |
| IRhythm Technologies (IRTC) | United States | $4.334B | 0.00 |
| Privia Health (PRVA) | United States | $2.788B | 208.91 |
| Enovis (ENOV) | United States | $1.951B | 12.07 |
| Schrodinger (SDGR) | United States | $1.898B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.712B | 0.00 |
| Phreesia (PHR) | United States | $1.483B | 0.00 |
| Omnicell (OMCL) | United States | $1.428B | 30.80 |
| Azenta (AZTA) | United States | $1.197B | 55.74 |
| 10x Genomics (TXG) | United States | $1.053B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.595B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.539B | 0.00 |
| Talkspace (TALK) | United States | $0.527B | 313.00 |
| Veradigm (MDRX) | United States | $0.450B | 0.00 |
| Standard BioTools (LAB) | United States | $0.437B | 0.00 |
| TruBridge (TBRG) | United States | $0.393B | 0.00 |
| Claritev (CTEV) | United States | $0.346B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.286B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.221B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.209B | 0.00 |
| Pulmonx (LUNG) | United States | $0.144B | 0.00 |
| American Well (AMWL) | United States | $0.114B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.095B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.094B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.083B | 0.00 |
| CareCloud (CCLD) | United States | $0.074B | 3.18 |
| 111 (YI) | China | $0.070B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.063B | 0.00 |
| HeartBeam (BEAT) | United States | $0.062B | 0.00 |
| Outset Medical (OM) | United States | $0.042B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.040B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |